M. Kavitha et al. / Tetrahedron Letters 52 (2011) 1658–1662
1661
Rostovtsev, V. V.; Noodleman, L.; Sharpless, K. B.; Fokin, V. V. J. Am. Chem. Soc.
2005, 127, 210–216.
1H), 1.4 (s, 9H); 13C NMR (75 MHz, CDCl3): dC 170.9, 154.8, 142.9, 136.1, 133.3,
128.9, 128.9, 128.8, 128.6, 127.2, 126.6, 122.7, 120.5, 80.3, 58.7, 57.8, 28.2; IR
2. (a) Huisgen, R. Angew. Chem. 1963, 75, 604–637; (b) Huisgen, R. Angew. Chem.
1963, 2, 565–598; (c) Huisgen, R. In Padwa, A., Ed.; 1,3-Dipolar Cycloaddition
Chemistry; Wiley: New York, 1984; pp 1–176; (d) Huisgen, R. Process Chem.
1961, 357–369; (e)Comprehensive Organic Synthesis; Trost, B. M., Ed.; Pergamon:
Oxford, 1991; Vol. 4, pp 1069–1109; for a review of asymmetric 1,3-dipolar
cycloaddition reactions, see (f) Gothelf, K. V.; Jorgensen, K. A. Chem. Rev. 1998,
98, 863–909; for a review of synthetic applications, see (g) Mulzer, J. Org. Synth.
Highlights 1991, 77–95.
3. Selected recent reviews; (a) Nandivada, H.; Jiang, X.; Lahann, J. Adv. Mater. 2007,
19, 2197–2208; (b) Angell, Y. L.; Burgess, K. Chem. Soc. Rev. 2007, 36, 1674–1689;
(c) Fournier, D.; Hoogenboom, R.; Schubert, U. S. Chem. Soc. Rev. 2007, 36, 1369–
1380; (d) Moses, J. E.; Moorhouse, A. D. Chem. Soc. Rev. 2007, 36, 1249–1262; (e)
Lutz, J.-F. Angew. Chem., Int. Ed. 2007, 46, 1018–1025; (f) Dondoni, A. Chem. Asian
J. 2007, 2, 700–708.
4. (a) Dyrager, C.; Börjesson, K.; Dinér, P.; Elf, A.; Albinsson, B.; Wilhelmsson, L. M.;
Grotli, M. Eur. J. Org. Chem. 2009, 1515–1521; (b) Scrafton, D. K.; Taylor, J. E.;
Mahon, M. F.; Fossy, J. S.; James, T. D. J. Org. Chem. 2008, 73, 2871–2874.
5. (a) Whiting, M.; Tripp, J. C.; Lin, Y. C.; Lindstrom, W.; Olson, A. J.; Elder, J. H.;
Sharpless, K. B.; Fokin, V. V. J. Med. Chem. 2006, 49, 7697–7710; (b) Youcef, R. A.;
Santos, M. D.; Roussel, S.; Baltaze, J. P.; Lubin-Germain, N.; Uziel, J. J. Org. Chem.
2009, 74, 4318–4323; (c) Sekiguchi, H.; Muranaka, K.; Osada, A.; Ichikawa, S.;
Matsuda, A. Bioorg. Med. Chem. 2010, 18, 5732–5737; (d) Junior, E. N. D. S.;
Guimaraes, T. T.; Menna-Barreto, R. F. S.; Pinto, M. D. C. F. R.; Simone, C. A. D.;
Pessoa, C.; Cavalcanti, B. C.; Sabino, J. R.; Andrade, C. K. Z.; Goulart, M. O. F.;
Castro, S. L. D.; Pinto, A. V. Bioorg. Med. Chem. 2010, 18, 3224–3230; (e) Kaval, N.;
Ermolat’ev, D.; Appukkuttan, P.; Dehaen, W.; Kappe, C. O.; Eycken, E. V. D. J.
Comb. Chem. 2005, 7, 490–502; (f) Tron, G. C.; Pirali, T.; Billington, R. A.;
Canonico, P. L.; Sorba, G.; Genazzani, A. A. Med. Res. Rev. 2008, 28, 278–308.
6. Nair, V.; George, T. G. Tetrahedron Lett. 2000, 41, 3199–3201.
(KBr): m ;
max 3439, 2975, 2928, 1711, 1495, 1238, 1163, 1048, 946, 750, 695 cmꢁ1
MS (ESI) m/z 435 (100) [M+H]+; HRMS calcd for C24H26N4NaO4 [M+Na]+:
457.1846; found, 457.185.
Compound 3e: semi solid; 1H NMR (300 MHz, CDCl3): dH 9.14 (s, 1H), 8.78 (s, 1H),
8.27 (dd, J = 8.3, 21.1 Hz, 1H), 8.04 (s, 1H), 7.73 (d, J = 15.1 Hz, 1H), 7.48–7.01 (m,
6H), 6.57 (d, J = 14.8 Hz, 1H), 5.52 (s, 1H), 5.38 (s, 1H); 13C NMR (75 MHz, CDCl3):
dC 153.5, 150.9, 150.8, 142.7, 142.1, 137.3, 137.2, 129.0, 128.99, 128.9, 128.4,
126.7, 124.6, 123.8, 123.4, 123.1, 122.7, 122.4, 121.5, 58.3, 58.1; IR (KBr): mmax
3449, 1725, 1638, 1280, 1112, 944, 741, 697 cmꢁ1; MS (ESI) m/z 307 (100)
[M+H]+; HRMS calcd for C17H15N4O2 [M+H]+: 307.119; found, 307.1192.
Compound 3f: solid; mp 90–92 °C; 1H NMR (500 MHz, CDCl3): dH 7.69–7.62 (m,
2H), 7.45–7.26 (m, 5H), 7.16 (d, J = 8.0 Hz, 2H), 7.10–7.02 (m, 3H), 5.23 (s, 2H),
3.69 (q, J = 6.6, 13.9 Hz, 1H), 2.42 (d, J = 7.3 Hz, 2H), 1.88–1.77 (m, 1H), 1.50 (d,
J = 7.3 Hz, 3H), 0.88 (d, J = 6.6 Hz, 6H); 13C NMR (75 MHz, CDCl3): dC 174.5, 143.3,
140.6, 137.2, 133.3, 129.3, 128.9, 128.8, 127.1, 126.6, 122.7, 122.0, 120.7, 57.8,
44.97, 44.91, 30.1, 22.3, 18.2; IR (KBr):
1150, 1013, 952, 753, 694 cmꢁ1; MS (ESI) m/z 390 (100) [M+H]+; HRMS calcd for
24H28N3O2[M+H]+: 390.2176; found, 390.216.
Compound 3g: solid; mp 102–104 °C;
= +4.5 (c 1.0, CHCl3); 1H NMR
mmax 2956, 2926, 1728, 1510, 1451, 1227,
C
½ ꢀ
a 2D8
(300 MHz, CDCl3): dH 7.82 (s, 1H), 7.71 (d, J = 14.7 Hz, 1H), 7.48–7.23 (m, 5H),
7.11 (d, J = 14.7 Hz, 1H), 5.28 (t, J = 6.6 Hz, 1H), 4.38 (t, J = 6.7 Hz, 1H), 4.01 (t,
J = 7.3 Hz, 1H), 1.76–1.53 (m, 8H), 1.52–1.35 (m, 2H); 13C NMR (75 MHz, CDCl3):
dC 148.3, 133.3, 129.0, 128.0, 126.7, 122.9, 121.9, 118.8, 110.7, 70.5, 69.4, 36.2,
35.1, 25.1; IR (KBr): mmax 2926, 1660, 1453, 1227, 1116, 1042, 951, 821,
692 cmꢁ1; MS (ESI) m/z 312 (100) [M+H]+; HRMS calcd for C18H22N3O2 [M+H]+:
312.1707; found, 312.1704.
Compound 3h: solid; mp 92–93 °C; 1H NMR (300 MHz, CDCl3): dH 8.31 (s, 1H),
7.73 (d, J = 14.35 Hz, 1H), 7.50–7.43 (m, 2H), 7.42–7.32 (m, 3H), 7.26 (d,
J = 14.9 Hz, 1H), 3.12 (t, J = 6.8 Hz, 2H), 1.87–1.75 (m, 2H), 1.4 (br s, 2H), 1.04 (t,
J = 7.55 Hz, 3H); 13C NMR (75 MHz, CDCl3): dC 132.9, 129.2, 129.0, 126.9, 123.9,
7. (a) Evans, D. A.; Faul, M. M.; Bilodeau, M. T. J. Org. Chem. 1991, 56, 6744–6746;
(b) Nozaki, H.; Nisikawa, Y.; Kawanisi, M.; Noyori, R. Tetrahedron 1967, 23,
2173–2179.
122.4, 122.2, 41.5, 29.6, 17.4, 13.7; IR (KBr): mmax 3445, 2961, 2086, 1678, 1634,
1529, 1450, 1253, 1128, 769, 693 cmꢁ1; MS (ESI) m/z 228 (100) [M+H]+; HRMS
8. The reaction of vinyl azide (E/Z 1:1) from 1a with 2a:
calcd for C14H18N3 [M+H]+ 228.1495; found, 228.1488.
O
O
N
AcO
AcO
N
N
N3
2a
O
O
Ph
AcO
AcO
Cu turnings, Na Ascorbate,
Sat. CuSO4, 60 oC, 6 h
3a
E/Z ratio 1:1
72% yield, E/Z ratio 9:1
9. General experimental procedure: To a deoxygenated solution of cinnamic acid
(1.0 mmol) and NaN3 (1.5 mmol) in dry acetonitrile (CH3CN), a deoxygenated
solution of CAN (2.5 mmol) in the same solvent was added dropwise at 0 °C and
the reaction temperature was raised to 25–30 °C. After stirring for 10 h at room
temperature, anhydrous sodium acetate (CH3COONa) (1.5 mmol) was added and
the reaction was heated to 65 °C. After stirring for 2 h, the alkyne compound
(0.9 mmol), copper turnings (10 mol%), CuSO4 solution (0.5 mL, 1 M) and
Compound 3i: solid; mp 96–98 °C; 1H NMR (300 MHz, CDCl3): dH 8.04 (s, 1H),
7.89–7.74 (m, 1H), 7.65 (d, J = 7.3 Hz, 2H), 7.43–7.28 (m, 6H), 7.27–7.19 (m, 2H),
6.53 (d, J = 9.6 Hz, 1H); 13C NMR (75 MHz, CDCl3): dC 128.9, 128.7, 128.4, 126.6,
125.8, 125.7, 123.4, 123.3, 123.0, 119.0, 116.5; IR (KBr): mmax 3450, 2925, 2108,
1705, 1632, 1456, 1313, 1269, 1176, 1044, 753, 688 cmꢁ1; MS (ESI) m/z 248
(100) [M+H]+; HRMS calcd for C16H14N3 [M+H]+: 248.1182.; found, 248.1176.
Compound 3j: solid; mp 96–98 °C; ½ ꢀ
a 2D5 = +27.4 (c 1.0, CHCl3); 1H NMR
sodium ascorbate (NaASc) (10 mol%) were added at
a time. The reaction
(300 MHz, CDCl3): dH 7.82–7.61 (m, 2H), 7.49–7.24 (m, 4H), 7.18–7.06 (m,
2H), 5.18–4.96 (m, 1H), 4.36–3.94 (m, 2H), 1.58 (s, 3H), 1.48 (s, 3H), 1.43–1.19
(m, 9H); 13C NMR (75 MHz, CDCl3): dC 159.8, 134.4, 130.0, 127.1, 123.5, 123.0,
121.1, 120.8, 119.8, 119.3, 118.3, 115.5, 114.7, 114.3, 114.2, 113.4, 111.9, 55.3,
mixture was refluxed (65 °C) for 4–6 h. After completion of the reaction
(monitored by TLC), the reaction mass was filtered through Celite. The volatiles
were removed on a rotary evaporator and subsequent column chromatography
over silica gel (60–120 mesh) gave E/Z inseperable mixture of triazoles in 60–
71% yields.
55.2, 29.7; IR (KBr): mmax 3458, 2979, 1693, 1658, 1388, 1378, 1255, 1172, 1093,
749, 694 cmꢁ1; MS (ESI) m/z 371 (100) [M+H]+; HRMS calcd for C20H27N4O3
[M+H]+: 371.2078; found, 371.2094.
Compound 3a: semi solid; ½a D30
ꢀ
= +56.5 (c 1.0, CHCl3); 1H NMR (300 MHz, CDCl3):
dH 7.89 (s, 1H), 7.74 (d, J = 14.7 Hz, 1H), 7.47–7.25 (m, 5H), 7.15 (d, J = 14.7 Hz,
1H), 5.92–5.77 (m, 2H), 5.29 (d, J = 9.6 Hz, 1H), 5.15 (br s, 1H), 4.91 (d,
J = 12.2 Hz, 1H), 4.75 (d, J = 12.2 Hz, 1H), 4.21–4.17 (m, 1H), 4.14–4.05 (m, 2H),
2.11–2.00 (m, 6H); 13C NMR (75 MHz, CDCl3): dC 170.5, 170.0, 143.9, 129.3,
128.7, 128.5, 128.3, 127.1, 123.7, 123.0, 122.2, 93.6, 93.3, 66.8, 65.0, 62.6, 60.8,
20.7, 20.6; IR (KBr): mmax 2951, 2107, 1742,1642, 1453, 1371, 1234, 1034, 768,
698 cmꢁ1; MS (ESI) m/z 414 (100) [M+H]+; HRMS calcd for C21H23N3NaO6
[M+Na]+: 436.1479; found, 436.149.
Compound 3k: solid; mp 96–98 °C; 1H NMR (300 MHz, CDCl3): dH 8.03–7.90 (m,
2H), 7.7 (d, J = 14.7 Hz, 1H), 7.50 (d, J = 7.7 Hz, 1H), 7.37–6.89 (m, 6H), 6.82 (d,
J = 8.1 Hz, 1H), 6.46 (d, J = 16.0 Hz, 1H), 5.34 (s, 2H), 4.24 (q, J = 7.0, 14.0 Hz, 2H),
3.82 (s, 3H), 1.33 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3): dC 167.4, 156.6,
144.4, 139.6, 131.5, 130.0, 128.6, 123.0, 122.1, 121.5, 120.0, 119.3, 118.8, 114.5,
112.7, 112.0, 62.5, 60.4, 55.2, 14.3; IR (KBr): mmax 3450, 2925, 2108, 1705, 1632,
1456, 1313, 1269, 1176, 1044, 753, 688 cmꢁ1; MS (ESI) m/z 406 (100) [M+H]+;
HRMS calcd for C23H24N3O4 [M+H]+: 406.1761; found, 406.1781.
Compound 3b: solid; mp 96–98 °C; 1H NMR (300 MHz, CDCl3): dH 8.02–7.92 (m,
2H), 7.7 (d, J = 14.7 Hz, 1H), 7.24–7.52 (m, 7H), 7.15 (d, J = 14.7 Hz, 1H), 7.04 (d,
J = 8.3 Hz, 1H), 6.94 (t, J = 7.50 Hz, 1H), 6.46 (d, J = 16.5 Hz, 1H), 5.3 (s, 2H), 4.22
(q, J = 7.0, 14.0 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): dC
167.3, 156.5, 144.3, 139.5, 133.3, 131.4, 129.0, 128.8, 128.5, 126.6, 122.7, 122.1,
121.4, 120.0, 118.8, 112.7, 62.5, 60.3, 14.2; IR (KBr): mmax 3410, 3077, 2924,
Compound 3l: semi solid; 1H NMR (300 MHz, CDCl3): dH 7.73–7.59 (m, 2H), 7.38–
6.84 (m, 7H), 6.76–6.50 (m, 2H), 5.29–5.05 (m, 2H), 3.88–3.80 (m, 3H), 3.76–3.68
(m, 1H), 2.48–2.39 (m, 2H), 1.91–1.75 (m, 1H), 1.54–1.40 (m, 3H), 0.94–0.81 (m,
6H); 13C NMR (75 MHz, CDCl3): dC 174.5, 174.2, 159.9, 159.8, 143.3, 142.6, 140.7,
140.6, 137.2, 134.7, 134.0, 130.0, 129.3, 129.2, 127.1, 127.0, 124.3, 123.3, 123.1,
123.0, 121.9, 120.7, 120.5, 119.2, 114.7, 114.4, 113.4, 112.9, 112.0, 57.7, 57.6,
55.2, 55.1, 49.8, 49.5, 44.9, 44.8, 30.1, 29.6, 29.3, 22.3, 18.3, 18.2; IR (KBr): mmax
3450, 2925, 2108, 1705, 1632, 1456, 1313, 1269, 1176, 1044, 753, 688 cmꢁ1; MS
(ESI) m/z 420 (100) [M+H]+; HRMS calcd for C25H30N3O3 [M+H]+: 420.2282;
found, 420.2293.
2955, 1904, 1711, 1632, 1451, 1313, 1272, 1162, 1036, 949, 866, 751,691 cmꢁ1
;
MS (ESI) m/z 376 (100) [M+H]+; HRMS calcd for C22H21N3NaO3 [M+Na]+:
398.1475; found, 398.1473.
Compound 3c: semi solid; ½a D30
ꢀ
= ꢁ28.2 (c 1.0, CHCl3); 1H NMR (300 MHz, CDCl3):
dH 7.88 (s, 1H), 7.65 (d, J = 15.1 Hz, 1H), 7.38–7.17 (m, 5H), 7.04 (d, J = 14.5 Hz,
1H), 4.7 (d, J = 12.0 Hz, 1H), 4.57 (d, J = 12.0 Hz, 1H), 4.18–4.00 (m, 3H), 1.34 (d,
J = 6.8 Hz, 3H), 1.22 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3): dC 172.8, 145.0,
133.3, 128.8, 128.6, 126.5, 122.7, 121.7, 120.1, 74.2, 63.2, 60.8, 18.4, 14.0; IR
(KBr): mmax 3467, 2938, 2077, 1738, 1634, 1453, 1210, 1117, 1023, 974, 751,
695 cmꢁ1; MS (ESI) m/z 302 (100) [M+H]+; HRMS calcd for C16H19N3O3 [M+Na]+:
324.1319; found, 324.1323.
Compound 3m: semi solid; 1H NMR (300 MHz, CDCl3): dH 7.59 (d, J = 9.0 Hz, 1H),
7.48 (s, 1H), 7.34–7.20 (m, 2H), 7.02–6.68 (m, 6H), 6.48 (d, J = 9.8 Hz, 1H), 3.81
(s, 3H), 3.71 (s, 3H); 13C NMR (75 MHz, CDCl3): dC 159.8, 141.2, 135.0, 134.4,
130.0, 127.2, 127.1, 123.5, 123.0, 121.1, 120.9, 118.3, 115.8, 115.5, 114.7, 114.3,
114.2, 113.4, 112.0, 55.3, 55.2; IR (KBr): mmax 3455, 2928, 2076, 1734, 1642,
1454, 1378, 1262, 1156, 773, 688 cmꢁ1; MS (ESI) m/z 308 (100) [M+H]+; HRMS
calcd for C18H18N3O2 [M+H]+: 308.1394; found, 308.1407.
Compound 3d: solid mp 108–110 °C; ½ ꢀ
a 2D8 = +1.3 (c 1.0, CHCl3); 1H NMR
Compound 3n: semi solid; 1H NMR (300 MHz, CDCl3): dH 8.17 (d, J = 8.3 Hz, 1H),
7.97 (s, 1H), 7.64 (s, 1H), 7.53 (d, J = 7.5 Hz, 1H), 7.38–7.16 (m, 4H), 6.93–6.81
(300 MHz, CDCl3): dH 7.69 (d, J = 6.7 Hz, 2H), 7.62 (s, 1H), 7.44–7.27 (m, 8H),
7.03 (d, J = 14.1 Hz, 1H), 5.60–5.45 (m, 1H), 5.39–5.21 (m, 3H), 4.17–4.02 (m,